Ethical Limits On Immune Modulation
Ethical Limits on Immune Modulation
1. Introduction
Immune modulation means changing or controlling the activity of the human immune system through medicines, biological treatments or medical procedures. The immune system protects the body from infections, harmful bacteria and viruses.
Sometimes, the immune system becomes weak and cannot fight diseases properly. In other situations, it becomes overactive and attacks healthy body cells. Doctors use immune modulation to control these problems.
Examples include immunotherapy, vaccines, immune-suppressing medicines and treatments that regulate immune cells.
Although these treatments can save lives, they also create ethical concerns about patient safety, informed consent, medical risks and equal access to healthcare.
2. Meaning and Types
Immune modulation can be divided into four main types:
A. Immune Stimulation: It increases immune activity to help the body fight infections or diseases.
B. Immune Suppression: It reduces immune activity, especially in patients suffering from autoimmune diseases or receiving organ transplants.
C. Immune Regulation: It controls excessive immune responses to prevent damage to healthy tissues.
D. Cellular Immunotherapy: It uses modified or specially prepared immune cells to attack diseases such as certain cancers.
These treatments must be used carefully because excessive stimulation or suppression can harm the body.
3. Ethical Limits
A. Patient Safety
Immune modulation may cause serious side effects. Excessive immune stimulation can damage healthy organs, while excessive suppression can increase the risk of infections. Doctors must carefully evaluate the patient's condition before recommending treatment.
B. Informed Consent
Patients must receive clear information about the benefits, risks, possible complications and alternative treatments. No patient should be forced to accept immune-modulating treatment without valid consent, except where the law recognises specific exceptions.
C. Human Dignity
Every patient must be treated with respect. Medical decisions should not be based on discrimination, financial status or personal characteristics.
D. Long-Term Effects
Some immune treatments may have effects that continue after treatment ends. Therefore, patients should receive proper medical monitoring and follow-up care.
E. Equal Access
Advanced immunotherapy can be expensive. Poor patients may not be able to afford these treatments. Healthcare institutions should work towards fair access and avoid discrimination.
4. Legal Framework in India
Article 14: It guarantees equality before the law. It is relevant to preventing unfair discrimination in access to immune-modulating treatments.
Article 21: It protects life, personal liberty and human dignity. Medical treatment must respect patient safety and bodily autonomy.
Drugs and Cosmetics Act, 1940: It regulates the manufacture, distribution and sale of drugs in India. Immune-modulating medicines must comply with applicable regulatory requirements.
New Drugs and Clinical Trials Rules, 2019: These rules regulate clinical trials and certain new drugs. They provide requirements concerning informed consent, safety and protection of research participants.
Consumer Protection Act, 2019: It provides protection against deficient medical services and unfair practices where its legal requirements are satisfied.
5. Important Case Laws
A. Samira Kohli v. Dr. Prabha Manchanda (2008), 2 SCC 1
The Supreme Court explained the importance of informed consent in medical treatment.
Judgment: The Court held that doctors generally require valid consent before performing medical procedures.
Relevance: Before immune modulation, doctors must explain the treatment, its possible risks and available alternatives to patients.
B. Parmanand Katara v. Union of India (1989), 4 SCC 286
The Supreme Court emphasised the importance of protecting human life and providing timely medical assistance.
Judgment: The Court recognised that preservation of human life is of primary importance.
Relevance: Patients experiencing serious immune-related medical conditions should receive timely and appropriate medical care.
C. Indian Medical Association v. V.P. Shantha (1995), 6 SCC 651
The Supreme Court considered the application of consumer protection law to medical services.
Judgment: The Court recognised that medical services may fall within the scope of consumer protection law, subject to the applicable conditions.
Relevance: Patients may seek legal remedies where immune-modulating treatment involves deficient medical services.
D. Justice K.S. Puttaswamy v. Union of India (2017), 10 SCC 1
The Supreme Court recognised privacy as a fundamental right.
Judgment: The Court protected personal autonomy, privacy and dignity.
Relevance: Medical records and immune-related health information must be protected from unauthorised disclosure.
6. Legal Responsibilities
Doctors must examine patients properly before prescribing immune-modulating medicines. Hospitals must maintain medical records, explain treatment risks and provide appropriate follow-up care.
Researchers must obtain ethical approval before conducting clinical trials. Pharmaceutical companies must follow applicable drug regulations and provide accurate information about their products.
Negligent treatment, lack of valid consent, misleading information or regulatory violations may result in legal and professional consequences.
7. Conclusion
Immune modulation is an important medical development that helps treat infections, autoimmune diseases and certain cancers. However, changing immune-system activity can create serious health risks. Therefore, these treatments must follow medical standards, informed consent and legal regulations. The main objective should be to protect patient safety, human dignity and equal access to healthcare while ensuring responsible medical development.

comments